ATP-induced vasodilation in human skeletal muscle

Area of Science:

• Cardiovascular Physiology
• Pharmacology
• Endothelium Function

Background:

• Adenosine-5'-triphosphate (ATP) significantly impacts the cardiovascular system.
• The precise mechanism of ATP-induced vasodilation in humans remains unclear.
• Endothelium-derived relaxing factors (EDRFs) are proposed mediators of vasodilation.

Purpose of the Study:

• To investigate the mechanism of ATP-induced vasodilation in the human forearm.
• To determine the role of various endothelium-derived relaxing factors (EDRFs) in ATP-mediated vasodilation.
• To elucidate the signaling pathways involved in ATP's cardiovascular effects.

Main Methods:

• Utilized the perfused forearm technique to study vasodilation.
• Administered varying doses of Adenosine 5'-triphosphate (ATP).
• Infused inhibitors of cyclooxygenase (COX), Na+/K+-ATPase, K(Ca) channels (TEA), K(ATP) channels (glibenclamide), and nitric oxide synthesis (l-NMMA).

Main Results:

• ATP induced a dose-dependent forearm vasodilator response.
• This vasodilation was not inhibited by indomethacin, ouabain, TEA, or glibenclamide.
• Combined blockade of TEA, indomethacin, and l-NMMA did not fully inhibit ATP-induced vasodilation, suggesting involvement of other EDRFs.
• Similar non-specific inhibition was observed with sodium nitroprusside (SNP).

Conclusions:

• ATP-induced vasodilation in the human forearm is not mediated by the commonly studied EDRFs (COX products, NO, K(Ca), K(ATP) channels).
• Endothelium-independent mechanisms likely contribute to ATP's vasodilatory effects.
• Further studies are required to identify alternative EDRFs, such as carbon monoxide (CO), involved in ATP signaling.